Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSIW) Times Interest Earned (2022 - 2025)

TriSalus Life Sciences' Times Interest Earned history spans 4 years, with the latest figure at -$2.25 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 68.26% year-over-year to -$2.25; the TTM value through Dec 2025 reached -$4.86, up 58.47%, while the annual FY2025 figure was -$4.86, 58.47% up from the prior year.
  • Times Interest Earned reached -$2.25 in Q4 2025 per TLSIW's latest filing, up from -$6.17 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$2.25 in Q4 2025 to a low of -$11772.0 in Q4 2022.
  • Average Times Interest Earned over 4 years is -$2307.1, with a median of -$9.32 recorded in 2024.
  • The largest YoY upside for Times Interest Earned was 99.85% in 2024 against a maximum downside of 92.21% in 2024.
  • A 4-year view of Times Interest Earned shows it stood at -$11772.0 in 2022, then surged by 59.66% to -$4749.3 in 2023, then skyrocketed by 99.85% to -$7.1 in 2024, then surged by 68.26% to -$2.25 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Times Interest Earned are -$2.25 (Q4 2025), -$6.17 (Q3 2025), and -$5.15 (Q2 2025).